Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,851 | -8,394 | -14,144 | -8,840 | -43,924 |
| Depreciation Amortization | 122 | 106 | 101 | 201 | 672 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -7,962 |
| Accounts receivable | 698 | -323 | -123 | 1,110 | 24 |
| Other Working Capital | 102 | 460 | 607 | -3,888 | 1,920 |
| Other Operating Activity | -344 | 595 | 8,060 | -725 | 33,399 |
| Operating Cash Flow | $-9,273 | $-7,556 | $-5,500 | $-12,141 | $-15,871 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -8 | -5 | 72 |
| Purchase Of Investment | -597 | -618 | -494 | -299 | -7,256 |
| Sale Of Investment | 620 | 620 | 7,856 | 4,053 | 29,390 |
| Investing Cash Flow | $20 | $-2 | $7,355 | $3,749 | $22,207 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 245 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 8,907 | N/A | N/A |
| Common Stock Issued | 8,659 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,693 | 97 | 0 | 0 | 0 |
| Financing Cash Flow | $10,597 | $97 | $8,907 | $N/A | $N/A |
| Beginning Cash Position | 4,906 | 12,367 | 1,605 | 9,996 | 3,661 |
| End Cash Position | 6,250 | 4,906 | 12,367 | 1,605 | 9,996 |
| Net Cash Flow | $1,344 | $-7,461 | $10,763 | $-8,391 | $6,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,273 | -7,556 | -5,500 | -12,141 | -15,871 |
| Capital Expenditure | -4 | -4 | -8 | -5 | -3 |
| Free Cash Flow | -9,276 | -7,560 | -5,507 | -12,145 | -15,874 |